This study presents a pilot from the RAIDO Horizon Europe project, which focuses on leveraging reliable AI and data optimization across a range of sectors, including healthcare. The RAIDO healthcare pilot is focused on pharmacogenomics (PGx) and the development of a personalized preventive healthcare solution using an ethics-by-design approach. The project is still in development, but the ethical framework has played a critical role in ensuring the PGx solution will be acceptable to stakeholders when implemented. The pilot’s objective is to address key challenges in PGx, such as variability in the availability and comprehension of actionable genetic information, socioeconomic disparities, and healthcare professionals’ diverse understanding of PGx data. This paper presents how an ethics-by-design approach can support the responsible integration of AI within personalized preventive PGx, using RAIDO Pilot 3 as a case study.

Liston, P., Lohan, E., Dai, X., Braut, G.N., Santucci, R., Rufino, S., et al. (2026). Implementing an Ethics-by-Design Approach in Personalized Preventive Pharmacogenomics: A Pilot Study in Development. In Springer Series in Design and Innovation (pp.81-90). GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND : Springer Nature [10.1007/978-3-032-23073-7_9].

Implementing an Ethics-by-Design Approach in Personalized Preventive Pharmacogenomics: A Pilot Study in Development

Bellini, Emanuele;
2026-01-01

Abstract

This study presents a pilot from the RAIDO Horizon Europe project, which focuses on leveraging reliable AI and data optimization across a range of sectors, including healthcare. The RAIDO healthcare pilot is focused on pharmacogenomics (PGx) and the development of a personalized preventive healthcare solution using an ethics-by-design approach. The project is still in development, but the ethical framework has played a critical role in ensuring the PGx solution will be acceptable to stakeholders when implemented. The pilot’s objective is to address key challenges in PGx, such as variability in the availability and comprehension of actionable genetic information, socioeconomic disparities, and healthcare professionals’ diverse understanding of PGx data. This paper presents how an ethics-by-design approach can support the responsible integration of AI within personalized preventive PGx, using RAIDO Pilot 3 as a case study.
2026
9783032230720
Liston, P., Lohan, E., Dai, X., Braut, G.N., Santucci, R., Rufino, S., et al. (2026). Implementing an Ethics-by-Design Approach in Personalized Preventive Pharmacogenomics: A Pilot Study in Development. In Springer Series in Design and Innovation (pp.81-90). GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND : Springer Nature [10.1007/978-3-032-23073-7_9].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11590/565440
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact